Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor – a pilot study

Neurologia i Neurochirurgia Polska

Volumn 49, Issue 1, 2015, Pages 41-44

  Zadora, Przemyslaw ^a   Dabrowski, Wojciech ^a   Czarko, Katarzyna ^a   Smolen, Agata ^a   Kotlinska Hasiec, Edyta ^a   Wiorkowski, Krzysztof ^a   Sikora, Agnieszka ^a   Jarosz, Bozena ^a   Kura, Krzysztof ^a   Rola, Radosław ^a,b   Trojanowski, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Glial brain tumor; Glioblastoma; Neutrophil lymphocyte count ratio

Indexed keywords

ADJUVANT THERAPY; ARTICLE; BLOOD ANALYSIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; GLIOMA; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NEUTROPHIL LYMPHOCYTE COUNT RATIO; PILOT STUDY; PREDICTION; PREOPERATIVE EVALUATION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STEREOTACTIC BIOPSY; ADULT; AGED; BLOOD; BRAIN NEOPLASMS; CANCER GRADING; CYTOLOGY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; PREOPERATIVE PERIOD;

TUMOR MARKER;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM GRADING; NEUTROPHILS; PILOT PROJECTS; PREOPERATIVE PERIOD; TUMOR MARKERS, BIOLOGICAL;

EID: 84927679546     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/j.pjnns.2014.12.006     Document Type: Article

References (10)

1. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation and cancer. Cell 2010;140(6):883-99.
2. Malietzis G, Giacometti M, Kennedy RH, Athanasiou T, Aziz O, Jenkins JT. The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis. Ann Surg Oncol 2014. http://dx.doi.org/10.1245/s10434-014-3815-2
3. Steffens S, Köhler A, Rudolph R, Eggers H, Seidel C, Janssen M, et al. Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer 2012;12:399.
4. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 2008;67:257-62.
5. Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012;56(December (6)):2242-54.
6. Yuan D, Zhu K, Li K, Yan R, Jia Y, Dang C. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. J Surg Oncol 2014. http://dx.doi.org/10.1002/jso.23651
7. Cedrès S, Torrejon D, Martínez A, Martinez P, Navarro A, Zamora E, et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol 2012;14:864-9.
8. Del Prete A, Allavena P, Santoro G, Fumarulo R, Corsi MM, Mantovani A. Molecular pathways in cancer-related inflammation. Biochem Med 2011;21(3):264-75.
9. Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 2011;71 (7):2411-6.
10. Kataki A, Skandami V, Memos N, Nikolopoulou M, Oikonomou V, Androulis A, et al. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations. J Neurosurg Sci 2014;58(1):9-15.